Naloxone: all 147 studies that test it
Page 2 of 2. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- Neuropeptides in Human ReproductionCompletedNCT01952782Phase 1
- Effect of High Dose Naloxone on Secondary HyperalgesiaCompletedNCT01935206Phase 1
- Nasal Naloxone for Narcotic OverdoseStatus unknownNCT01912573Phase 4
- The Relationships Between the Noradrenergic, Opioid and Pain SystemWithdrawnNCT01851486Not applicable
- Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent SubjectsWithdrawnNCT01713803Phase 3
- Effects of Methylnaltrexone in Comparison to Naloxone on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time.CompletedNCT01596764Phase 1
- The Effects of ∆-9-THC and Naloxone in HumansCompletedNCT01591629Early Phase 1
- Transfer of Subjects From Subutex/Suboxone to RBP-6300CompletedNCT01582347Phase 2
- Clinical Trial on Binge Eating Disorder, Treatment With Naloxone SprayStatus unknownNCT01567670Phase 2/3
- Naloxone and Intravenous Methylnaltrexone Effects on Bladder FunctionCompletedNCT01367561Phase 1
- Randomized Trial of Intranasal Versus Intravenous Naloxone in Level of Consciousness in Suspected Opioid OverdoseCompletedNCT01293058Phase 2
- Drug-Drug Interaction Study Between Telaprevir and BuprenorphineCompletedNCT01275599Phase 1
- Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant PainCompletedNCT01167699Phase 3
- Naloxone Methadone Combination (NAMEKO)WithdrawnNCT01160432Not applicable
- A Comparison of Oxycodone/Naloxone and Oxycodone After Laparoscopic HysterectomyCompletedNCT01109511Phase 4
- Subjective Analgesic Effects of Naloxone and Virtual RealityStatus unknownNCT01105871Not applicable
- Naloxone for the Treatment of Opioid-Induced PruritusCompletedNCT01071057Phase 2/3
- Reversal of Ketamine Pharmacodynamic Effects With NaloxoneTerminatedNCT00921765Phase 4
- Efficacy of Intramuscular Naloxone 0.4mg. in Prophylaxis of Intrathecal Morphine Induced Pruritus After Cesarean SectionCompletedNCT00890942Not applicable
- Comparison of Two Dosage Strengths of Transdermal Fentanyl Versus Transdermal Buprenorphine and Placebo in Acute Pain Models in Healthy Volunteers.CompletedNCT00886002Phase 1
- Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent SubjectsCompletedNCT00829777Phase 1
- Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma PatientsTerminatedNCT00799201Phase 4
- Impact of Naloxone on the Analgesic Effect of Paracetamol in Healthy VolunteersCompletedNCT00750048Phase 1
- Pharmacokinetics of Fentanyl Following Intravenous and Oral Routes of Administration in Healthy VolunteersCompletedNCT00714558Phase 1
- Effect of Combined Use of Naloxone and Tramacet on Postop Analgesia in Elderly Patients Having Joint Replacement SurgeryCompletedNCT00679614Phase 3
- Randomized, Double-Blind Cross-Over Trial Of Buprenorphine and Low-Dose Naloxone Versus BuprenorphineCompletedNCT00679458Not applicable
- Drug Discrimination in Methadone-Maintained Humans Study 1CompletedNCT00593463Phase 1
- A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer PainCompletedNCT00513656Phase 2
- Impact of Low Dose Naloxone on Fentanyl Requirements in Pediatric ICU PatientsCompletedNCT00286052Phase 3
- Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1CompletedNCT00249574Not applicable
- Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid UsersCompletedNCT00158236Not applicable
- Abuse Potential of Buprenorphine/NaloxoneTerminatedNCT00149539Phase 2
- Blockade Efficacy of Buprenorphine/Naloxone For Opioid DependenceCompletedNCT00134888Not applicable
- Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid AbusersTerminatedNCT00134875Not applicable
- Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1CompletedNCT00078130Phase 3
- Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1CompletedNCT00032968Phase 3
- Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1CompletedNCT00032955Phase 3
- Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic PainStatus unknownNCT00020605Phase 3
- Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14CompletedNCT00015340Phase 4
- Buprenorphine and Naloxone Combination Study - 10CompletedNCT00015288Phase 1
- Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1CompletedNCT00015171Phase 3
- Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1CompletedNCT00015028Phase 2
- Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based PracticeCompletedNCT00007527Phase 4
- Trial of Buprenorphine/Naloxone for Opiate Dependence - 2CompletedNCT00000353Phase 2
- Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9CompletedNCT00000344Phase 2
- Buprenorphine Combination Tablet Feasibility - 1CompletedNCT00000298Phase 2
- Buprenorphine Pharmacology Related to Addiction Treatment - 18CompletedNCT00000236Phase 2